# A Research Study Looking at Blood Sugar Control in People With Type 2 Diabetes Previously Treated With Premix Insulin and Initiating Treatment With Insulin Degludec/Liraglutide (IDegLira) in Local Clinical Practice in Croatia

> **NCT05479591** · — · WITHDRAWN · sponsor: **Novo Nordisk A/S**

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** IDegLira

## Key facts

- **NCT ID:** NCT05479591
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-07-30
- **Primary completion:** 2023-04-30
- **Final completion:** 2023-04-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Sponsor decision
- **Last updated:** 2022-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05479591

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05479591, "A Research Study Looking at Blood Sugar Control in People With Type 2 Diabetes Previously Treated With Premix Insulin and Initiating Treatment With Insulin Degludec/Liraglutide (IDegLira) in Local Clinical Practice in Croatia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05479591. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*